轻中度COPD患者,
这三种情况下必须治疗!
LAMA治疗COPD:
早上好还是晚上好?
结果(如图2所示):
夜间LAMA给药组中,245人(5%)出现了主要结局(病情严重急性加重或死亡),早晨LAMA给药组中,249人(5%)出现了主要结局,两组间主要结局差异无统计学意义(P=0.93);
夜间LAMA给药降低了入ICU的风险(P=0.0077);
两组间COPD中度加重(P=0.52)、NIV(P=0.51)或全因死亡率(P=0.57)的发生率无统计学意义。
图2 夜间/早晨LAMA给药两组间的差异比较
AECOPD气道廓清技术,
哪些是国际共识?
[1]Z. Wang.Identifying Patients Requiring Necessary Treatment in Mild to Moderate COPD.
[2]Pradeesh Sivapalan,et al.Evening Administration of Long-Acting Muscarinic Antagonists in Chronic Obstructive Pulmonary Disease to Prevent Exacerbations.
[3]A. Spinou,et al.International consensus on airway clearance techniques for acute exacerbations of chronic obstructive pulmonary disease (AECOPD): a modified Delphi study.